Home » Topics » BioWorld Science

BioWorld Science
RSS

New impotence treatment deemed approvable by FDA

Nov. 22, 1996

RA test from Hemagen Diagnostics cleared for marketing

Nov. 22, 1996

Antiparkinsonian skin patch enters pivotal phase II trial

Nov. 22, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Japanese researchers disclose anti-HIV agents

Nov. 22, 1996

Antitumor lactam isolated by Japanese researchers

Nov. 22, 1996

New carbapenems from Takeda

Nov. 22, 1996

Otsuka describes novel cephems

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...